An opportunity for established and upcoming medical device manufacturers to validate commercial opportunities in China’s booming MedTech market.
China’s Medical Device market is worth over £90 billion, second only to the US, and growing around 30% year-on-year (YOY). China's government-led 'Healthy China 2030’ strategy sets out ambitious aims to tackle the systemic health risks it faces, from an ageing population to huge regional disparity in the provision of healthcare. As a result, unique and advanced medical devices and solutions from overseas are in high demand in certain sectors of the industry.
This session will take companies through the three key stages of market entry into China:
Participating companies will also have the chance to book a tailored 1:1 consultation with any of our providers speaking at the session:
In collaboration with:
Santander Corporate & Commercial is a brand name of Santander UK plc (which also uses the brand name Santander Corporate & Investment Banking). Registered Offices: 2 Triton Square, Regent's Place, London, NW1 3AN, United Kingdom. Registered Numbers 2294747 and 1533123 respectively. Registered in England and Wales. Santander UK plc is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority. Our Financial Services Register number is 106054. You can check this on the Financial Services Register by visiting the FCA’s website www.fca.org.uk/register.
Santander and the flame logo are registered trademarks.